Endometriosis: causes, diagnosis, and treatment options-review article for healthcare providers

In: International journal of health sciences · 2018 · vol. 2(S1) , pp. 297–312 · doi:10.53730/ijhs.v2ns1.15234 · W4403879828
article OA: diamond CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-06

This review synthesizes current literature on endometriosis, detailing its causes, pathophysiology, diagnosis, and treatment options for healthcare providers to improve patient management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text

This review article synthesizes current literature on endometriosis, focusing on its causes, epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment options for healthcare providers, using a narrative review approach across genetic, environmental, and mechanistic studies. It reports that endometriosis affects an estimated 6–10% of reproductive-aged women, is associated with symptoms such as dysmenorrhea and subfertility, and that diagnosis is confirmed via surgical visualization and biopsy, while pathophysiology is linked to aberrant immune responses and hormonal dysregulation. A key limitation is that the paper is not a systematic review or meta-analysis, so the strength and comparability of evidence across topics are not formally quantified. This paper is centrally about endometriosis — it reviews causes, diagnosis, and treatment options in detail.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis is characterized by the presence of functional, estrogen-responsive endometrial-like tissue outside the uterine cavity, leading to chronic inflammation and significant impairment of quality of life. Its economic burden in the United States exceeds $49 billion, driven largely by healthcare costs and productivity losses for affected individuals. Aim: This review aims to provide healthcare providers with a comprehensive understanding of endometriosis, including its causes, epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment options. Methods: A review of current literature was conducted to gather information on the various aspects of endometriosis, including genetic, environmental, and epidemiological factors, along with its mechanisms of pain and subfertility. Results: Endometriosis affects approximately 6–10% of reproductive-aged women and is associated with risk factors such as early menarche and nulliparity. The condition presents with diverse symptoms, including dysmenorrhea and subfertility. Diagnosis is confirmed through surgical visualization and biopsy of lesions. The pathophysiology includes aberrant immune responses and hormonal dysregulation, contributing to chronic pain and infertility. Conclusion: Understanding the complexities of endometriosis is crucial for effective diagnosis and treatment. Given its multifactorial nature and significant impact on women's health, ongoing research is essential to improve treatment strategies and patient outcomes.
Full text 12,219 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Keywords

Endometriosis, chronic pain, subfertility, diagnosis, treatment options, epidemiologyAbstract

Background

Endometriosis is characterized by the presence of functional, estrogen-responsive endometrial-like tissue outside the uterine cavity, leading to chronic inflammation and significant impairment of quality of life. Its economic burden in the United States exceeds $49 billion, driven largely by healthcare costs and productivity losses for affected individuals. Aim: This review aims to provide healthcare providers with a comprehensive understanding of endometriosis, including its causes, epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment options. Methods: A review of current literature was conducted to gather information on the various aspects of endometriosis, including genetic, environmental, and epidemiological factors, along with its mechanisms of pain and subfertility. Results: Endometriosis affects approximately 6–10% of reproductive-aged women and is associated with risk factors such as early menarche and nulliparity. The condition presents with diverse symptoms, including dysmenorrhea and subfertility. Diagnosis is confirmed through surgical visualization and biopsy of lesions. The pathophysiology includes aberrant immune responses and hormonal dysregulation, contributing to chronic pain and infertility. Conclusion: Understanding the complexities of endometriosis is crucial for effective diagnosis and treatment. Given its multifactorial nature and significant impact on women's health, ongoing research is essential to improve treatment strategies and patient outcomes. Downloads

References

Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 2012;27:1292–9. DOI: https://doi.org/10.1093/humrep/des073 Balasch J, Creus M, Fábregues F, Carmona F, Ordi J, Martinez-Román S, et al. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996;11:387–91. DOI: https://doi.org/10.1093/HUMREP/11.2.387 Carter JE. Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain. J Am Assoc Gynecol Laparosc 1994;2:43–7. DOI: https://doi.org/10.1016/S1074-3804(05)80830-8 Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017;215:220–3. DOI: https://doi.org/10.1016/j.ejogrb.2017.06.028 Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW, Zondervan KT. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update 2014;20:702–16. DOI: https://doi.org/10.1093/humupd/dmu015 Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011;118:691–705. DOI: https://doi.org/10.1097/AOG.0b013e31822adfd1 Bulun SE, Monsivais D, Kakinuma T, Furukawa Y, Bernardi L, Pavone ME, et al. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med 2015;33:220–4. DOI: https://doi.org/10.1055/s-0035-1554053 Nothnick WB, Falcone T, Joshi N, Fazleabas AT, Graham A. Serum miR-451a levels are significantly elevated in women with endometriosis and recapitulated in baboons (Papio anubis) with experimentally-induced disease. Reprod Sci 2017;24:1195–1202. DOI: https://doi.org/10.1177/1933719116681519 Muzii L, Bianchi A, Bellati F, Cristi E, Pernice M, Zullo M, et al. Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril 2007;87:362–6. DOI: https://doi.org/10.1016/j.fertnstert.2006.06.055 Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction. Semin Reprod Med 2017;35:88–97. DOI: https://doi.org/10.1055/s-0036-1597123 As-Sanie S, Kim J, Schmidt-Wilcke T, Sundgren PC, Clauw DJ, Napadow V, et al. Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain. J Pain 2016;17:1–13. DOI: https://doi.org/10.1016/j.jpain.2015.09.008 Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril 2010;94:1894–9. DOI: https://doi.org/10.1016/j.fertnstert.2009.09.043 Matorras R, Corcostegui B, Esteban J, Ramon O, Prieto B, Expósito A, et al. Fertility in women with minimal endometriosis compared with normal women was assessed by means of a donor insemination program in unstimulated cycles. Am J Obstet Gynecol 2010;203:345.e1–6. DOI: https://doi.org/10.1016/j.ajog.2010.05.019 Prapas Y, Goudakou M, Matalliotakis I, Kalogeraki A, Matalliotaki C, Panagiotidis Y, et al. History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes. Reprod Biomed Online 2012;25:543–8. DOI: https://doi.org/10.1016/j.rbmo.2012.07.020 Kitajima M, Dolman MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicle recruitment and atresia in cortex derived from ovaries with endometrioma. Fertil Steril 2014;101:1031–7. DOI: https://doi.org/10.1016/j.fertnstert.2013.12.049 Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol 2016;215:589.e1–6. DOI: https://doi.org/10.1016/j.ajog.2016.05.029 Chapron C, Santulli P, de Ziegler D, Noel JC, Anaf V, Streuli I, et al. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod 2012;27:702–11. DOI: https://doi.org/10.1093/humrep/der462 Guerriero S, Condous G, van den Bosch T, Valentin L, Leone FP, Van Schoubroeck D, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol 2016;48:318–32. DOI: https://doi.org/10.1002/uog.15955 Abrao MS, Gonçalves MO, Dias JA Jr, Podgaec S, Chamie LP, Blasbalg R. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007;22:3092–7. DOI: https://doi.org/10.1093/humrep/dem187 Bazot M, Malzy P, Cortez A, Roseau G, Amouyal P, Daraï E. Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 2007;30:994–1001. DOI: https://doi.org/10.1002/uog.4070 Bazot M, Bornier C, Duberbnard G, Roseau G, Cortez A, Daraï E. Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod 2007;22:1457–63. DOI: https://doi.org/10.1093/humrep/dem008 Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017;107:523–32. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.009 Nisenblat V, Prentice L, Bossuyt PM, Farquhar C, Hull ML, Johnson N. Combination of the non-invasive tests for the diagnosis of endometriosis. The Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD012281. DOI: 10.1002/14651858.CD012281. DOI: https://doi.org/10.1002/14651858.CD012281 Management of endometriosis. Practice Bulletin No. 114. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223–36. DOI: https://doi.org/10.1097/AOG.0b013e3181e8b073 Bedaiwy MA, Pope R, Henry D, Zanotti K, Mahajan S, Hurd W, et al. Standardization of laparoscopic pelvic examination: a proposal of a novel system. Minim Invasive Surg 2013;2013:153235. DOI: https://doi.org/10.1155/2013/153235 Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 2014;101:927–35. DOI: https://doi.org/10.1016/j.fertnstert.2014.02.012 Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15:441–61. DOI: https://doi.org/10.1093/humupd/dmp007 Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008;90:1583–8. DOI: https://doi.org/10.1016/j.fertnstert.2007.08.051 Muzii L, Di Tucci C, Achilli C, Di Donato V, Musella A, Palaia I, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol 2016;214:203–11. DOI: https://doi.org/10.1016/j.ajog.2015.08.074 Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017;107:533–6. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.003 Vercellini P, Bracco B, Mosconi P, Roberto A, Alberico D, Dhouha D, et al. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertil Steril 2016;105:734–43.e3. DOI: https://doi.org/10.1016/j.fertnstert.2015.11.016 Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006;21:248–56. DOI: https://doi.org/10.1093/humrep/dei290 Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. The Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD008475. DOI: 10.1002/14651858.CD008475.pub2. DOI: https://doi.org/10.1002/14651858.CD008475 Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60:75–9. DOI: https://doi.org/10.1016/S0015-0282(16)56039-7 Alkatout I, Mettler L, Beteta C, Hedderich J, Jonat W, Schollmeyer T, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol 2013;20:473–81. DOI: https://doi.org/10.1016/j.jmig.2013.01.019 Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med 2017;377:28–40. DOI: https://doi.org/10.1056/NEJMoa1700089 Published How to Cite Issue Section Copyright (c) 2018 International journal of health sciences This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose. Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrheainfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK